Drug Trial Radar · NCT05291676
Systems Investigation of Vaccine Responses in Aging and Frailty
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
96
Planned (sponsor's estimate)
Start
Nov 6, 2023
Primary completion
May 2029
Study completion May 2029
Sponsor
- Lead sponsor
- Yale UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)
- First posted
- Mar 23, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will compare the immune response signatures (including immunologic, transcriptomic and metabolomic) of the two influenza vaccines approved for use in adults age 65 and over (Fluad and Fluzone High-Dose).
Conditions
- Influenza
Interventions
FluzoneBiological
Fluzone High-Dose 0.7 ml intramuscular injection, standard as recommended by manufacturer
FluadBiological
Fluad Quadrivalent, MF59 adjuvanted 0.5 ml intramuscular injection, standard as recommended by manufacturer
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in production of IL-6 in monocytes to assess innate immune inflammatory responseTime frame: Baseline and at Day 2, 7, and 28 post-vaccine
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Yale School of Medicine
New Haven, Connecticut · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.